Evidence map›Paper›PMID 21607134›Full record

ArticleWorld journal of stem cells2011

Adipose-derived stromal cells: Their identity and uses in clinical trials, an update.

Louis Casteilla, Valérie Planat-Benard, Patrick Laharrague, Béatrice Cousin

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in World journal of stem cells, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02298023 phase2completednot on this mapstarted 2014, after this paper: background citation

Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells: Phase II Double-Blind Placebo-Controlled Randomized Clinical Trials.

TypeinterventionalSponsorSeoul National University HospitalRan2014 to 2018Enrolled24ConditionsRotator Cuff TearArmsallogenic adipose stem cell injection, fibrin glue/normal saline injection, normal saline injection
NCT03260452 nacompletednot on this mapstarted 2018, after this paper: background citation

Comparison of Hematopoietic Stem Cell Activity in Adipose Tissue From Type 2 Diabetic Patients and Healthy Volunteers: Proof of Concept Study. White Adipose Tissue and Type 2 Diabetes Onset: WAT2DO

TypeinterventionalSponsorUniversity Hospital, ToulouseRan2018 to 2019Enrolled20ConditionsType2 DiabetesArmsAbdominal subcutaneous biopsies and Blood test
3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 229 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular Regulation of Thermogenic Mechanisms in Beige Adipocytes.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Effects of adipose tissue-derived mesenchymal stem cells and/or sildenafil citrate in experimental colon anastomosis model.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2022
    Article
  18. Review
  19. Nutritional Regulation of Mammary Tumor Microenvironment.Frontiers in cell and developmental biology · 2022
    Review
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Louis CasteillaLouis Casteilla, Valérie Planat-Benard, Patrick Laharrague, Béatrice Cousin, Université de Toulouse, UPS, UMR 5241 Métabolisme, Plasticité et Mitochondrie, BP 84225, F-31 432 Toulouse Cedex 4, France.
Valérie Planat-Benard
Patrick Laharrague
Béatrice Cousin
Université Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In adults, adipose tissue is abundant and can be easily sampled using liposuction. Largely involved in obesity and associated metabolic disorders, it is now described as a reservoir of immature stromal cells. These cells, called adipose-derived stromal cells (ADSCs) must be distinguished from the crude stromal vascular fraction (SVF) obtained after digestion of adipose tissue. ADSCs share many features with mesenchymal stem cells derived from bone marrow, including paracrine activity, but they also display some specific features, including a greater angiogenic potential. Their angiogenic properties as well as their paracrine activity suggest a putative tumor-promoting role for ADSCs although contradictory data have been published on this issue. Both SVF cells and ADSCs are currently being investigated in clinical trials in several fields (chronic inflammation, ischemic diseases, etc.). Apart from a phase III trial on the treatment of fistula, most of these are in phase I and use autologous cells. In the near future, the end results of these trials should provide a great deal of data on the safety of ADSC use.

Indexed as

Cell therapyMesenchymal stem cellsStroma cellsWhite adipose tissue

Identifiers

PMID21607134
PMCPMC3097937
OpenAlexW2038099377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.